09/08/2015 - 2:06pm

The acquisitions will bring InvaGen’s 32 products and 40 approved abbreviated new drug applications, as well as Exelan’s management team and institutional market under the company’s control. 

09/08/2015 - 11:48am

Data from recent years suggests that the increasing prevalence of diabetes may be leveling off.

09/08/2015 - 11:33am

The Centers for Disease Control and Prevention has launced its new program, “Prescription Drug Overdose: Prevention for States,” which aims to invest in 16 states currently battling an epidemic of prescription drug overdoses. 

09/08/2015 - 10:52am

The program asks individuals living with pain and providers to design the ideal experience in the exam room that would foster dialogue about prescription drug abuse, deterrent technology and the effect of pain.

09/08/2015 - 9:27am

 Mylan on Tuesday announced the launch of its generic version of Bayer’s Yasmin (drospirenone and ethinyl estradiol) birth control tablets.

09/08/2015 - 8:35am

Under the terms of the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.

09/04/2015 - 10:03am

Ancino this week launched its rivastigmine patch, a generic version of the Exelon patch.

09/03/2015 - 2:45pm

Lupin Pharmaceuticals on Thursday announced the launch of its duloxetine delayed-release, a generic version of Cymbalta.

09/03/2015 - 8:41am

 The drug, a biosimilar version of Amgen’s Neupogen, is the first biosimilar drug to launch in the U.S.